Aaron Robert Roseth Acquires 13,500 Shares of Global Medical REIT (NYSE:XRN) Stock

Global Medical REIT Inc. (NYSE:XRN) COO Aaron Robert Roseth purchased 13,500 shares of the stock in a transaction on Wednesday, August 12th. The stock was bought at an average cost of $36.73 per share, for a total transaction of $495,855.00. Following the completion of the acquisition, the chief operating officer owned 13,500 shares in the company, valued at approximately $495,855. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Global Medical REIT Trading Up 1.9%

Shares of XRN stock opened at $37.28 on Friday. The firm has a 50 day moving average price of $36.62 and a two-hundred day moving average price of $35.81. The company has a quick ratio of 0.68, a current ratio of 0.59 and a debt-to-equity ratio of 1.37. The company has a market capitalization of $493.59 million, a PE ratio of 10.02 and a beta of 1.09. Global Medical REIT Inc. has a 12-month low of $29.05 and a 12-month high of $39.93.

Global Medical REIT (NYSE:XRN) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $4.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $3.95. Global Medical REIT had a return on equity of 13.31% and a net margin of 36.82%.The company had revenue of $39.75 million during the quarter. As a group, analysts predict that Global Medical REIT Inc. will post 2.89 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages have commented on XRN. BMO Capital Markets upped their price objective on Global Medical REIT from $39.00 to $40.00 and gave the company a “market perform” rating in a report on Monday, July 13th. Wall Street Zen downgraded Global Medical REIT from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Raymond James Financial started coverage on shares of Global Medical REIT in a research report on Wednesday, June 17th. They issued a “market perform” rating for the company. Compass Point reissued a “neutral” rating and issued a $38.00 target price (down from $50.00) on shares of Global Medical REIT in a research report on Thursday, May 7th. Finally, Zacks Research upgraded shares of Global Medical REIT to a “hold” rating in a research note on Wednesday, July 22nd. Two research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $40.25.

Key Global Medical REIT News

Here are the key news stories impacting Global Medical REIT this week:

• Positive Sentiment: CEO Mark Okey Decker, Jr. bought 8,000 shares at $35.88 and an additional 6,875 shares at $35.92, while COO Aaron Robert Roseth purchased 13,500 shares at $36.73. Director Charles Fitzgerald also acquired 14,000 shares at $35.78. The reported purchases represent more than $1.5 million of direct insider buying, a potentially bullish signal. Global Medical REIT CEO Purchases Shares
• Positive Sentiment: Global Medical REIT’s latest quarterly results significantly exceeded expectations: earnings per share were $4.78 versus the $0.83 consensus estimate, with revenue of $39.75 million. The company also reported a 36.82% net margin and 13.74% return on equity, providing fundamental support for investor interest.
• Neutral Sentiment: Analyst opinion remains mixed, with two Buy ratings, five Holds and one Sell. The average price target is $40.25, above the recent trading range, but Compass Point maintains a $38 target while Citizens JMP has a $42 target. The overall consensus rating is Hold.
• Neutral Sentiment: Institutional investors own approximately 57.52% of XRN. Recent filings show several funds increasing positions, although the disclosed transactions are not necessarily a near-term catalyst.
• Neutral Sentiment: Coverage also discusses Global Medical REIT’s rebranding and transition to Chiron Real Estate, which may create uncertainty about the company’s identity and strategic direction. Chiron Real Estate rebrand article
• Negative Sentiment: The REIT remains relatively leveraged, with a debt-to-equity ratio of 1.68 and current and quick ratios of 0.68. High debt and limited liquidity could weigh on valuation if interest rates stay elevated or healthcare property conditions weaken.

Institutional Investors Weigh In On Global Medical REIT

A number of hedge funds and other institutional investors have recently made changes to their positions in XRN. Invesco Ltd. boosted its stake in shares of Global Medical REIT by 30.5% in the second quarter. Invesco Ltd. now owns 1,518,668 shares of the company’s stock valued at $10,524,000 after buying an additional 355,355 shares during the period. Alyeska Investment Group L.P. bought a new position in Global Medical REIT during the 3rd quarter worth $9,997,000. Marshall Wace LLP increased its stake in Global Medical REIT by 2,208.2% during the 2nd quarter. Marshall Wace LLP now owns 291,708 shares of the company’s stock worth $2,022,000 after acquiring an additional 279,070 shares during the period. Heartland Advisors Inc. raised its holdings in Global Medical REIT by 177.4% in the 4th quarter. Heartland Advisors Inc. now owns 423,460 shares of the company’s stock valued at $14,288,000 after acquiring an additional 270,786 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC acquired a new position in Global Medical REIT in the 3rd quarter valued at $7,798,000. 57.52% of the stock is currently owned by institutional investors and hedge funds.

Global Medical REIT Company Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.